Literature DB >> 33569599

Pirh2, an E3 ligase, regulates the AIP4-p73 regulatory pathway by modulating AIP4 expression and ubiquitination.

Rami Abou Zeinab1, H Helena Wu1, Yasser Abuetabh1, Sarah Leng1, Consolato Sergi2, David D Eisenstat3,4, Roger P Leng1.   

Abstract

Pirh2 is an E3 ligase belonging to the RING-H2 family and shown to bind, ubiquitinate and downregulate p73 tumor suppressor function without altering p73 protein levels. AIP4, an E3 ligase belonging to the HECT domain family, has been reported to be a negative regulatory protein that promotes p73 ubiquitination and degradation. Herein, we found that Pirh2 is a key regulator of AIP4 that inhibits p73 function. Pirh2 physically interacts with AIP4 and significantly downregulates AIP4 expression. This downregulation is shown to involve the ubiquitination of AIP4 by Pirh2. Importantly, we demonstrated that the ectopic expression of Pirh2 inhibits the AIP4-p73 negative regulatory pathway, which was restored when depleting endogenous Pirh2 utilizing Pirh2-siRNAs. We further observed that Pirh2 decreases AIP4-mediated p73 ubiquitination. At the translational level and specifically regarding p73 cell cycle arrest function, Pirh2 still ensures the arrest of p73-mediated G1 despite AIP4 expression. Our study reveals a novel link between two E3 ligases previously thought to be unrelated in regulating the same effector substrate, p73. These findings open a gateway to explain how E3 ligases differentiate between regulating multiple substrates that may belong to the same family of proteins, as it is the case for the p53 and p73 proteins.
© The Author(s) 2021. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33569599      PMCID: PMC8086772          DOI: 10.1093/carcin/bgab009

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  46 in total

1.  Structure of p73 DNA-binding domain tetramer modulates p73 transactivation.

Authors:  Abdul S Ethayathulla; Pui-Wah Tse; Paola Monti; Sonha Nguyen; Alberto Inga; Gilberto Fronza; Hector Viadiu
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-02       Impact factor: 11.205

2.  Enhanced Mdm2 activity inhibits pRB function via ubiquitin-dependent degradation.

Authors:  Chiharu Uchida; Seiichi Miwa; Kyoko Kitagawa; Takayuki Hattori; Tomoyasu Isobe; Sunao Otani; Toshiaki Oda; Haruhiko Sugimura; Takehiko Kamijo; Keizou Ookawa; Hideyo Yasuda; Masatoshi Kitagawa
Journal:  EMBO J       Date:  2004-12-02       Impact factor: 11.598

3.  p73 is a simian [correction of human] p53-related protein that can induce apoptosis.

Authors:  C A Jost; M C Marin; W G Kaelin
Journal:  Nature       Date:  1997-09-11       Impact factor: 49.962

Review 4.  p73 tumor suppressor protein: a close relative of p53 not only in structure but also in anti-cancer approach?

Authors:  Joanna Zawacka-Pankau; Anna Kostecka; Alicja Sznarkowska; Elisabeth Hedström; Anna Kawiak
Journal:  Cell Cycle       Date:  2010-02-16       Impact factor: 4.534

5.  p73 Expression in human normal and tumor tissues: loss of p73alpha expression is associated with tumor progression in bladder cancer.

Authors:  Pere Puig; Paola Capodieci; Marija Drobnjak; David Verbel; Carol Prives; Carlos Cordon-Cardo; Charles J Di Como
Journal:  Clin Cancer Res       Date:  2003-11-15       Impact factor: 12.531

6.  Lysine 63-linked polyubiquitin chain may serve as a targeting signal for the 26S proteasome.

Authors:  Yasushi Saeki; Tai Kudo; Takayuki Sone; Yoshiko Kikuchi; Hideyoshi Yokosawa; Akio Toh-e; Keiji Tanaka
Journal:  EMBO J       Date:  2009-01-15       Impact factor: 11.598

7.  Certain pairs of ubiquitin-conjugating enzymes (E2s) and ubiquitin-protein ligases (E3s) synthesize nondegradable forked ubiquitin chains containing all possible isopeptide linkages.

Authors:  Hyoung Tae Kim; Kwang Pyo Kim; Fernando Lledias; Alexei F Kisselev; K Matthew Scaglione; Dorota Skowyra; Steven P Gygi; Alfred L Goldberg
Journal:  J Biol Chem       Date:  2007-04-10       Impact factor: 5.157

8.  Human PIRH2 enhances androgen receptor signaling through inhibition of histone deacetylase 1 and is overexpressed in prostate cancer.

Authors:  Ian R Logan; Luke Gaughan; Stuart R C McCracken; Vasileia Sapountzi; Hing Y Leung; Craig N Robson
Journal:  Mol Cell Biol       Date:  2006-09       Impact factor: 4.272

9.  Role of Pirh2 in mediating the regulation of p53 and c-Myc.

Authors:  Anne Hakem; Miyuki Bohgaki; Bénédicte Lemmers; Elisabeth Tai; Leonardo Salmena; Elzbieta Matysiak-Zablocki; Yong-Sam Jung; Jana Karaskova; Lilia Kaustov; Shili Duan; Jason Madore; Paul Boutros; Yi Sheng; Marta Chesi; P Leif Bergsagel; Bayardo Perez-Ordonez; Anne-Marie Mes-Masson; Linda Penn; Jeremy Squire; Xinbin Chen; Igor Jurisica; Cheryl Arrowsmith; Otto Sanchez; Samuel Benchimol; Razqallah Hakem
Journal:  PLoS Genet       Date:  2011-11-17       Impact factor: 5.917

Review 10.  p73 Alternative Splicing: Exploring a Biological Role for the C-Terminal Isoforms.

Authors:  Polina Vikhreva; Gerry Melino; Ivano Amelio
Journal:  J Mol Biol       Date:  2018-05-04       Impact factor: 5.469

View more
  3 in total

Review 1.  DNA damage response revisited: the p53 family and its regulators provide endless cancer therapy opportunities.

Authors:  Yasser Abuetabh; H Helena Wu; Chengsen Chai; Habib Al Yousef; Sujata Persad; Consolato M Sergi; Roger Leng
Journal:  Exp Mol Med       Date:  2022-10-07       Impact factor: 12.153

Review 2.  The Role of E3 Ligase Pirh2 in Disease.

Authors:  Alexandra Daks; Olga Fedorova; Sergey Parfenyev; Ivan Nevzorov; Oleg Shuvalov; Nickolai A Barlev
Journal:  Cells       Date:  2022-04-30       Impact factor: 7.666

3.  Regulation of p73 by Pirh2-AIP4 loop.

Authors:  H Helena Wu; Rami Abou Zeinab; Roger P Leng
Journal:  Aging (Albany NY)       Date:  2021-09-14       Impact factor: 5.682

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.